跳至主要内容
临床试验/NCT02204787
NCT02204787已完成1 期

A Double Blind Sham Controlled Trial of tDCS for Treatment of Negative Symptoms in Patients With Schizophrenia

University Hospital, Montpellier2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
60
试验地点
2
主要终点
Scale for the Assessment of Negative Symptoms

研究概览

简要总结

The aim of this study is to evaluate the therapeutic efficacy of a neuromodulation technique, tDCS (transcranial direct current stimulation) used as a complementary treatment on negative symptoms. 60 patients will be randomized into two groups (active tDCS vs sham tDCS) and will be assessed after the intervention, 1 and 3 months after.Secondary outcomes shall include neuropsychological assessment, general symptomatology, extrapyramidal symptoms and social functioning.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Schizophrenia with prominent negative symptoms

排除标准

  • other psychiatric or neurological diseases
  • specific tDCS limitations

结局指标

主要结局

Scale for the Assessment of Negative Symptoms

时间窗: up to 3 months after intervention

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验